About Qairn
Qairn is a company based in Paris (France) founded in 2020 by Paul-Antoine Tremolet and Francois Cancelloni.. Qairn has raised $1.43 million across 1 funding round. Qairn offers products and services including UBAQ DocPromo, NAYACT Transparency, UBAQ MedInfo, and UBAQademie. Qairn operates in a competitive market with competitors including Datapharm, RXTransparent, TraceMed, PharmaQR and Trievr, among others.
- Headquarter Paris, France
- Founders Paul-Antoine Tremolet, Francois Cancelloni
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.43 M (USD)
in 1 rounds
-
Latest Funding Round
$1.43 M (USD), Seed
Jul 21, 2022
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qairn
Qairn offers a comprehensive portfolio of products and services, including UBAQ DocPromo, NAYACT Transparency, UBAQ MedInfo, and UBAQademie. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for examining and validating promotional documents in health regulations.
Tool for handling advantages and compliance in health sector processes.
Platform for managing medical data and regulatory submissions efficiently.
Educational tools for learning regulatory automation in healthcare.
Funding Insights of Qairn
Qairn has successfully raised a total of $1.43M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.43 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.4M
-
First Round
First Round
(21 Jul 2022)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Seed - Qairn | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Qairn
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Qairn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Qairn Comparisons
Competitors of Qairn
Qairn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Datapharm, RXTransparent, TraceMed, PharmaQR and Trievr, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regulatory compliance software for pharma and healthcare professionals is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based supply chain software for pharmacies is provided.
|
|
| domain | founded_year | HQ Location |
Offers e-verification software for pharmacies and hospitals to ensure compliance.
|
|
| domain | founded_year | HQ Location |
Offers cloud-based solutions for regulatory compliance in pharmacy.
|
|
| domain | founded_year | HQ Location |
Request management platform for pharma compliance, audits, and recalls.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Qairn
When was Qairn founded?
Qairn was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Qairn located?
Qairn is headquartered in Paris, France.
Is Qairn a funded company?
Qairn is a funded company, having raised a total of $1.43M across 1 funding round to date. The company's 1st funding round was a Seed of $1.43M, raised on Jul 21, 2022.
What does Qairn do?
Qairn was established in 2020 and is headquartered in Paris, France. Solutions focused on regulatory and compliance management for pharmaceutical laboratories are delivered. Workflow automation for regulatory documents is enabled, alongside electronic signature management and audit trailing of documents. Operations support document handling and oversight within the pharmaceutical sector, ensuring adherence to standards.
Who are the top competitors of Qairn?
Qairn's top competitors include Datapharm, RXTransparent and PharmaQR.
What products or services does Qairn offer?
Qairn offers UBAQ DocPromo, NAYACT Transparency, UBAQ MedInfo, and UBAQademie.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.